公司資料
NRX Pharmaceuticals, Inc. 股價、新聞與催化劑
- 股票代碼:
- NRXP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.45 USD (-3.09%)
收盤價
最後更新: 2026年8月24日
167M USD
市值
股價為何變動
As of Aug 24, 2026, NRXP closed down 3.09% at $3.45. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
NRX Pharmaceuticals is a neuroscience and psychiatric-care company focused on severe depression and related central nervous system conditions. Its story has centered on hard-to-treat mental-health disorders.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, NRX sits in specialty biotechnology.
商業模式特徵
The company depends on clinical progress, regulatory steps, and the ability to create value in CNS medicine.
生技產業定位
NRX is a high-risk CNS name whose valuation is driven by clinical and strategic developments.
未來催化劑
- NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update. The company still needs a clean execution step.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。